BioSpace News Archive

The two-year pilot utilizes the Wiley Open Access Account solution to allow VIVA researchers to publish in fully gold open access journals using a central fund for article publication charges

More likely to seek expanded responsibilities

H.C. Wainwright & Co. acted as financial advisor to the Company in connection with the Offering.

Strainprint™ Technologies Ltd., Gynica & Lumir Lab to release custom questionnaire to select eligible participants for world-leading medical cannabis research

Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all investors that purchased Abiomed, Inc.

SnapMD, an award-winning full-service enterprise telehealth technology innovator and solutions provider, today announced it has successfully completed a meticulous third-party examination of its data security processes and controls under the SOC 2 + HITRUST framework, a significant, two-tiered healthcare technology compliance accomplishment.

The latest Morgan Stanley Investor Pulse Poll finds that high net worth (HNW) investors are increasingly attracted to digital technology while at the same time concerned about cybersecurity.

NavaDerm, a leading dermatology services organization in the Northeast and a BelHealth Investment Partners (“BelHealth”) portfolio company, announced a partnership with Laser & Skin Surgery Center of New York, Midtown Dermatology and their affiliated entities (“LSSCNY” or the “Company”).

The Critical Path Institute (C-Path) and the National Organization for Rare Disorders® (NORD) will host a meeting on Tuesday, September 17 in Bethesda, MD to formally launch development of a new rare disease data and analytics platform.

Phase One patient data from a potential therapy targeting a single KRAS mutation, formerly considered “undruggable,” has been introduced in 2019.